Telesis Bio, Inc. (TBIO) Covered Calls

You can sell covered calls on Telesis Bio, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for TBIO (prices last updated Thu 4:16 PM ET):

Telesis Bio, Inc. (TBIO) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
0.35 0.00 0.32 0.38 19K - 0.0
Covered Calls For Telesis Bio, Inc. (TBIO)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
May 17 2.5 0.00 0.38 0.0% 0.0%
Jun 21 2.5 0.00 0.38 0.0% 0.0%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Translate Bio, Inc., a clinical-stage messenger RNA (mRNA) therapeutics company, develops medicines to treat diseases caused by protein or gene dysfunction. The company is developing MRT5005, which is in Phase I/II clinical trial for the treatment of cystic fibrosis; and MRT5201 to treat ornithine transcarbamylase deficiency. The company was formerly known as RaNA Therapeutics, Inc. and changed its name to Translate Bio, Inc. in June 2017. Translate Bio, Inc. was founded in 2011 and is headquartered in Lexington, Massachusetts.